Cargando…

Is There a Role for Risk-Reducing Bilateral Breast Surgery in BRCA1/2 Ovarian Cancer Survivors? An Observational Study

Background: Risk-reducing surgeries are an option for cancer risk management in BRCA1/2 individuals. However, while adnexectomy is commonly recommended in breast cancer (BC) survivors, risk-reducing bilateral breast surgery (RRBBS) is controversial in ovarian cancer (OC) survivors due to relapse rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Daniela, Fernandes, Sofia, Miguel, Isália, Fragoso, Sofia, Vaz, Fátima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528403/ https://www.ncbi.nlm.nih.gov/pubmed/37754482 http://dx.doi.org/10.3390/curroncol30090567

Ejemplares similares

Hereditary breast cancer and ancestry in the Madeira archipelago: an exploratory study
por: Miguel, Isália, et al.
Publicado: (2021)

Challenges and Considerations on Risk-Reducing Surgery in BRCA1/2 Patients with Advanced Breast Cancer
por: Vasconcelos de Matos, Leonor, et al.
Publicado: (2021)

BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
por: Stefansson, Olafur A., et al.
Publicado: (2012)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2019)

Bilateral Pseudomonas aeruginosa endophthalmitis following bilateral simultaneous cataract surgery
por: Kashkouli, Mohsen Bahmani, et al.
Publicado: (2007)

Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study
por: Winship, Amy Louise, et al.
Publicado: (2019)

Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA Mutation Carrier
por: Maeshima, Yurina, et al.
Publicado: (2016)

Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
por: Steinmann, D, et al.
Publicado: (2001)

BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers
por: Loboda, Anna P., et al.
Publicado: (2023)

Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer
por: Sokolenko, Anna P., et al.
Publicado: (2022)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

Commentary: Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers
por: Glassey, Rachael, et al.
Publicado: (2017)

Characterization of BRCA Deficiency in Ovarian Cancer
por: Barbero, Giovanna, et al.
Publicado: (2023)

Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
por: Lee, Chee Khoon, et al.
Publicado: (2019)

Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland
por: Pallonen, Terhi Aino-Sofia, et al.
Publicado: (2022)

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
por: Arakelyan, Arsen, et al.
Publicado: (2021)

Biodegradable Bone Implants as a New Hope to Reduce Device-Associated Infections—A Systematic Review
por: Paiva, José C. C., et al.
Publicado: (2022)

BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer – an observational cohort study
por: Unni, Sudhir K., et al.
Publicado: (2016)

Hysterectomy at the time of risk-reducing surgery in BRCA carriers
por: Nair, Navya, et al.
Publicado: (2018)

The Novel Pathogenic Mutation c.849dupT in BRCA2 Contributes to the Nonsense-Mediated mRNA Decay of BRCA2 in Familial Breast Cancer
por: Li, Sanrong, et al.
Publicado: (2018)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
por: Metcalfe, Kelly A, et al.
Publicado: (2005)

One Case of a BRCA1 Germ Line Mutation Ovarian Carcinoma Patient Based on Abnormal Immunohistochemistry Finding
por: Kim, Hyun Joo, et al.
Publicado: (2014)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
por: Ferreyra, Yomali, et al.
Publicado: (2023)

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors
por: Demissei, Biniyam G., et al.
Publicado: (2022)

Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer
por: Vaca-Paniagua, Felipe, et al.
Publicado: (2012)

A survey of ovarian reserve and quality of life in female survivors of pediatric cancer
por: Nilsson, Sofia, et al.
Publicado: (2021)

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
por: Marchetti, Claudia, et al.
Publicado: (2014)

Bilateral breast in brothers - abreast
por: Shaikh, Altamash Mohammed Yusuf, et al.
Publicado: (2013)

Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients
por: Jarhelle, Elisabeth, et al.
Publicado: (2019)

Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
por: Conduit, Ciara, et al.
Publicado: (2021)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
por: Manchana, Tarinee, et al.
Publicado: (2020)

The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
por: C.E, Drechsel Katja, et al.
Publicado: (2022)

Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study
por: Maksimenko, Jelena, et al.
Publicado: (2022)

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients
por: Gallardo-Rincón, Dolores, et al.
Publicado: (2019)

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
por: Yazici, H, et al.
Publicado: (2000)

Screening for germline rearrangements in BRCA1 and BRCA2 in Norwegian families with breast or breast/ovarian cancer
por: Van Ghelue, M, et al.
Publicado: (2005)

Prostate Cancer Risk by BRCA2 Genomic Regions
por: Nyberg, Tommy, et al.
Publicado: (2020)

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
por: Ligtenberg, M J L, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_mqmmj9hfejjth9qk772enh5dbl